TG Therapeutics, Inc. Net Income 2011–2025
TG Therapeutics, Inc. reported $447.18M of net income for fiscal 2025. That was 1812.4% higher than fiscal 2024. Compared with fiscal 2020, the change was +260.1%.
| Fiscal year | Net Income | Net margin | Change (YoY) |
|---|---|---|---|
| FY 2025 | $447.18M | 72.6% | +1812.4% |
| FY 2024 | $23.38M | 7.1% | +84.5% |
| FY 2023 | $12.67M | 5.4% | +106.4% |
| FY 2022 | $-198.34M | -7121.5% | +43.0% |
| FY 2021 | $-348.10M | -5204.1% | -24.6% |
| FY 2020 | $-279.38M | -183803.3% | -61.6% |
| FY 2019 | $-172.87M | -113730.9% | +0.4% |
| FY 2018 | $-173.48M | -114132.9% | -46.4% |
| FY 2017 | $-118.48M | -77944.7% | -51.4% |
| FY 2016 | $-78.25M | -51482.2% | -24.3% |
| FY 2015 | $-62.95M | — | -12.8% |
| FY 2014 | $-55.78M | — | -172.4% |
| FY 2013 | $-20.48M | — | -13.3% |
| FY 2012 | $-18.07M | — | -2018.5% |
| FY 2011 | $-853,074 | — | — |
Source: TG Therapeutics, Inc. SEC filings — income statement (10-K). Computed deterministically; refreshed nightly (last updated August 2, 2026). Open TGTX 10-K filings at SEC EDGAR · Methodology · Download CSV.
How to read this history
TG Therapeutics, Inc. reported $447.18M of net income for fiscal 2025. That was 1812.4% higher than fiscal 2024. Compared with fiscal 2020, the change was +260.1%. Values remain missing when the cached filing does not disclose a comparable line item; they are never estimated. Stock splits, reorganizations and fiscal-calendar changes can reduce comparability.
Prepared and reviewed by the stockportfolio.pro research desk. Corrections: support@stockportfolio.pro.
See the full picture for TG Therapeutics, Inc.
Complete income statement, balance sheet and cash flow with trend on every row, 48 quarters, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open the interactive view — freeTG Therapeutics, Inc. — frequently asked questions
What is TG Therapeutics, Inc.'s net income?
TG Therapeutics, Inc. (TGTX) reported net income of $447.18M for fiscal year 2025, per its SEC filings.
Where does this data come from?
Figures are computed from TG Therapeutics, Inc.'s official SEC filings (income statement (10-K)), refreshed nightly. Not investment advice.